Innovation Agenda

Anticipated CNE Credit 5.5*

This continuing nursing education activity was approved by the Northeast Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation

 Time Activity / Session Location
7:15 - 9:00 AM Registration Foyer 
7:30 - 8:55 AM Breakfast (available 7:15-8:45am), Exhibits, Poster Session  Ballroom
7:30 - 8:55 AM Patient Assistance / Advocacy Presentation Breakfast Concord 
8:55 - 9:00 AM
Welcoming Remarks

Nicole Messier BSN, RN, OCN, ONN-CG, NAHPAC Co- Chair
Christian A. Thomas, MD - NNECOS President
State Rooms 
(Webster & Pierce) 
9:00 - 9:45 AM Survivorship in Advanced Disease 

Susan Gruber
Larry Dacey, MD
Blair Brooks, MD
State Rooms (Webster & Pierce)
9:45 - 10:15 AM  

Biosimilars 101: How “similar” are they?

Matthew Marston, Pharm.D., BCPS, BCOP
State Rooms
(Webster & Pierce)
10:15 - 10:45 AM Refreshment / Exhibit Break  / Posters
Foyer & Ballroom 
10:45 - 11:45 AM
Pancreatic Cancer Tumor Board

Janet R Ely, MSN, FNP, AOCNP, APCHN    
Diane Koeller, MS, MPH, LGC
Jennifer May, RD, CD
Nicole Messier BSN, RN, OCN, ONN-CG

Tumor board format presentation/discussion of a difficult patient case.
State Rooms
(Webster & Pierce)
11:50 AM - 12:30 PM ASCO Update: Oncology Care in the Current Administration

Amanda Schwartz, MPS
Director, Congressional Affairs at ASCO

A high level overview of ASCO’s policy setting and priorities. The presentation will include discussion of ASCO’s federal and state legislative activity as well as regulatory work with the Administration. Further, the speaker will address how attendees can get involved in advocacy on behalf of cancer care and research. Topics address will include; MACRA implementation, 340B, opioids, and federal funding for research. 
State Rooms
(Webster & Pierce)
12:30 - 1:30 PM Lunch / Exhibits / Posters
 Ballroom
1:30 - 2:30 PM 2017-2018 Drug Updates in Hematology/Oncology

Laura J. Hackett, PharmD, BCOP
Clinical Pharmacist – Hematology/Oncology
Dartmouth-Hitchcock Medical Center

Learn about new hematology/oncology agents granted FDA-approval in 2017-2018. This session will address genomic drug naming formulas, differentiate biosimilars from generic drugs, and define gene therapy.

State Rooms
(Webster & Pierce)
2:35 PM - 3:30 PM
Innovative Abstracts Podium Presentation
  • Retrospective QI study of antiā€estrogen
    adherence in women with estrogen receptor
    positive breast cancer - 
    Julie Bushey, MSN, RN, OCN, CCRP
  • Travel distance in a rural setting prolongs time
    to thoracic surgery evaluation but not time
    from evaluation to treatment for operable
    lung cancers -
     Timothy Millington, MD
  • Social Media usage among patients and
    healthcare providers in the northern New
    England cancer community - 
    Lukas Emery, DO & Bhavina Batukbhai, MD

State Rooms
(Webster & Pierce)
3:35 - 4:15 PM Genetics 101: Clinical Cancer Genetics

Diane Koeller, MS, MPH, LGC
Dana-Farber Cancer Institute

This talk will review the basics of cancer genetics, including sporadic versus hereditary cancers, somatic versus germline genetic mutations, common hereditary cancer syndromes, genetics referral guidelines and the impact of cancer genetics on cancer treatment.


State Rooms
(Webster & Pierce)
 4:15 - 4:20 PM Closing Remarks

Christian A. Thomas, MD - NNECOS President
State Rooms
(Webster & Pierce)
4:20 - 5:15 PM
Networking Reception & Prize Drawing
  • Make your own sundae (ice cream & sorbet)
  • Adult refreshments
Foyer


Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org

This website brought to you by:


Powered by Wild Apricot Membership Software